Sign in
Taking people in United StatesPhase 3

Smartphones for Opiate Addiction Recovery

Key facts

Who runs it
NYU Langone Health
Where
New York and Piscataway, United StatesSee the 2 sites
Trial code
Status
Recruiting
Phase
Phase 3
People taking part
225 people, planned
Started
1 Nov 2021
Expected to end
1 Dec 2027
Type of study
Interventional, 5 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Smartphone app
Record updated
23 June 2026

Who can take part

Age
18 years to 85 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 28 criteriaShow less

Who can take part

  • Patients:
  • Meet DSM-5 criteria for opioid-use disorder (heroin and/or prescription opioids)
  • Have entered, or expressed a clear intention to enter, an OUD treatment program that prescribes either methadone or buprenorphine
  • Any gender
  • 18 years of age and older
  • Have used opioids other than as specifically prescribed within thirty days prior to consent
  • In good-enough general health
  • Capacity to provide written informed consent as assessed by our Subject Comprehension Assessment Tool(subjects lacking the ability to consent will not be enrolled)
  • Able to speak English sufficiently to understand the study procedures and provide written informed consent to participate in the study; Study-Physician Participants
  • Licensed MD employed by the respective site, or at a clinical partner of the respective site, where they will act as participants and be part of the treatment team
  • Currently practicing in the treatment of OUD with either Buprenorphine or Methadone
  • Able to speak, read, and write English fluently and to provide informed consent in English; Clinician Participants
  • Licensed MSW, NP, or MD; who are not part of any treatment team within the study and may be employees of their respective sites or other treatment facilities
  • Currently practicing in the treatment of OUD with either Buprenorphine or Methadone
  • Able to speak, read, and write English fluently and to provide informed consent in English

Who cannot take part

  • Individuals receiving residential court-ordered substance abuse treatment; Study-Physician Participants
  • Severe, untreated or inadequately treated mental disorder (e.g., active psychosis, uncontrolled manic-depressive illness) as assessed by history and/or clinical interview
  • Serious medical, psychiatric or non-opioid substance use disorder that, in the opinion of a study physician, would make study participation hazardous to the participant or compromise study findings or would prevent the participant from completing the study. Examples include: (a) Disabling or terminal medical illness (e.g., uncompensated heart failure, cirrhosis or end-stage liver disease) as assessed by medical history, review of systems, physical exam and/or laboratory assessments
  • Patients:
  • Current severe alcohol, benzodiazepine, or other depressant or sedative hypnotic use likely to require a complicated medical detoxification (routine alcohol and sedative detoxifications may be included)
  • Suicidal or homicidal ideation that requires immediate attention
  • Presence of pain of sufficient severity as to require ongoing pain management with opioids
  • Pending legal action or other reasons that might prevent an individual from completing the study
  • Pregnancy as assessed by urine pregnancy testing
  • Breastfeeding of infants, as assessed by self-report
  • Prisoners, as defined by OHRP, are excluded from participation in the study
  • none; Clinician Participants
  • none

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 85 years old?

This trial is currently available in United States.

  • NYU LangoneNew York, United StatesContact: Paul GlimcherTaking people
  • Rutgers UniversityPiscataway, United StatesContact: Anna Konova, MDNot yet recruiting

About the trial

What the trial wants to find out

Treatments for opioid addiction exist, but effectiveness is compromised when subjects use illicit opiates during treatment. Reuse rates during treatment can be high, and reducing illicit opiate use during treatment has thus recently become a major NIDA policy goal. The 5-minute battery indicates the numerical probability that a patient will reuse illicit opiates within the next 7-10 days.

The 5 groups in the trial

  • Treatment-as-UsualNo study treatment, for comparison

    Participants will receive the same treatment as if they had not joined the study

  • Smartphone with dose changes after usingTreatment being tested

    Participants will have an app installed on their phone and have to complete a brief questionnaire and some days play a 2-4 minute game.

    Treatment: Smartphone app

  • Smartphone with dose changes before usingTreatment being tested

    Participants will have an app installed on their phone and have to complete a brief questionnaire and some days to play a 2-4 minute game.

    Treatment: Smartphone app

  • Focus group with Study PhysicansTreatment being tested

    Study physicians asked to participate in a focus group session or 1:1 interviews if unable to attend the focus group during year one of the study and once annually towards the end of years 2, 3, 4, and 5 of the study

    Treatment: Smartphone app

  • Focus group with CliniciansTreatment being tested

    Clinicians asked to participate in a 1:1 interview and a separate focus group at roughly the same time. Prior to the first structured interview with our study team, you will participate in a 1-hour training and familiarization session with the SOAR system using synthetic or training data.

    Treatment: Smartphone app

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Criteria questions
Built from NCT05033028, who can take part
Record updated
23 June 2026